Subscribe to these results:

Upcoming Workshops

  1. Register
  2. Register
  3. Register
  4. Register

Past Workshops

  1. Managing the Side Effects of ImmunotherapyPart II of New Trends in Immunotherapy
  2. Non-Hodgkin Lymphoma: Current Treatment Progress
  3. Understanding the Role of Immunotherapy in Treating CancerPart I of New Trends in Immunotherapy
  4. Diffuse Large B-Cell Lymphoma (DLBCL): Treatment Updates
  5. Update from the 2022 American Society of Hematology (ASH) Annual Meeting
  6. What’s New In Precision Medicine
  7. Update On Marginal Zone Lymphoma (MZL)
  8. Waldenstrom’s Macroglobulinemia (WM): Treatment Progress
  9. Progress in the Treatment of Non-Hodgkin Lymphoma (NHL)
  10. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  11. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
  12. Coping with the Stresses of Caregiving When Your Loved One Has Mantle Cell Lymphoma (MCL)Part II of Living with Mantle Cell Lymphoma (MCL)
  13. Diffuse Large B-Cell Lymphoma (DLBCL) Updates
  14. What’s New in Diagnostic Technologies for People Living with Blood CancersPart II of The Role of Diagnostic Technologies in Transforming the Treatment of People Living with Cancer
  15. Update from the 2021 American Society of Hematology (ASH) Annual Meeting
  16. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
  17. Update on CAR T-Cell Therapies
  18. Adjusting to Your Blood Cancer Treatment Over Time: Challenges and Opportunities of Taking Your Treatment on Schedule
  19. Updates from the 2020 American Society of Hematology (ASH) Annual Meeting
  20. Update on Diffuse Large B-Cell Lymphoma (DLBCL)
  21. Update on CAR-T Cell Therapy
  22. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  23. Taking Your Blood Cancer Treatment on Schedule
  24. Update on Diffuse Large B-Cell Lymphoma
  25. Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches
  26. The Emerging Role of Immunotherapy in the Treatment of Lymphoma
Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.